Paragon Biosciences, based in Chicago, is an incubator and an investor in biotechnology companies focused on developing drugs to treat diseases lacking any viable treatment. Paragon Biosciences’ portfolio includes companies developing therapies to deal with rare dermatological conditions, sleep and central nervous system disorders, Alzheimer’s and rare genetic oncology diseases (Premiergazette).
Their methods of identifying who is most likely to bring their ideas to fruition and then providing capital and infrastructure for those people allows the development of drugs more quickly for patients with unmet medical needs. By utilizing this approach, Paragon Biosciences is able to attract top investors.
Paragon provides more than simply capital. Paragon also delivers extensive expertise in all the legal and regulatory knowledge necessary to bring these drugs to the patients who need them. As well as business development expertise.
Since 2010 Jeff Aronin has been chairman and CEO of Paragon Biosciences. He has also been non-executive chairman of several of Paragon’s companies. Jeff Aronin was president and chief executive of Ovation Pharmaceuticals Inc. from 2000 to 2009 when the company was acquired by Lundbeck, Inc. and was president and chief executive officer of that company during the acquisition.
Mr. Aronin’s entrepreneurship and scientific vision that he has brought to Paragon has been instrumental in the development of over a dozen new drugs that have been approved for use by the FDA. He is also a philanthropist who supports several organizations, including the Cystic Fibrosis Foundation, Susan G. Komen, and Juvenile Diabetes Research Foundation among others.
MATTER is an incubator founded by Mr. Aronin with more than 200 startup companies of health care innovators currently being developed.
He contributes to educational causes as well, such as Jewish United Fund, Teaching Tolerance, US Holocaust Museum, Boys and Girls Clubs of Chicago, Junior Achievement and many others.
Jeff Aronin holds a BS degree from Northern Illinois University and an M.B.A, from DePaul University and lectures the University of Chicago Booth School of Business and Northwestern University’s Kellogg School of Management on entrepreneurship.